Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation.
Nichole T TannerMulugeta GebregziabherChanita Hughes HalbertElizabeth PayneLeonard E EgedeGerard A SilvestriPublished in: American journal of respiratory and critical care medicine (2015)
Black individuals screened with LDCT had decreased mortality from lung cancer. However, the demographics associated with improved LC survival were less commonly found in black individuals. The overall mortality in the NLST was higher for black individuals than white individuals, but improved in black individuals screened, suggesting that this subgroup may have had improved access to care. To realize the reductions in mortality from LC screening, dissemination efforts need to be tailored to meet the needs of this community.
Keyphrases
- quality improvement
- healthcare
- cardiovascular events
- risk factors
- clinical trial
- primary care
- mental health
- randomized controlled trial
- type diabetes
- simultaneous determination
- skeletal muscle
- adipose tissue
- phase iii
- insulin resistance
- high resolution
- pain management
- smoking cessation
- phase ii
- african american
- open label